您的购物车当前为空
AZD2389 is an effective and orally active FAP inhibitor that improves histological fibrosis and increases intact α2-AP, suitable for studying metabolic dysfunction-associated steatohepatitis.
别名 AZD-2389, AZD 2389
AZD2389 is an effective and orally active FAP inhibitor that improves histological fibrosis and increases intact α2-AP, suitable for studying metabolic dysfunction-associated steatohepatitis.

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 455 | 现货 | |
| 5 mg | ¥ 892 | 现货 | |
| 10 mg | ¥ 1,290 | 现货 | |
| 25 mg | ¥ 2,330 | 现货 | |
| 50 mg | ¥ 3,850 | 现货 | |
| 100 mg | ¥ 5,490 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 981 | 现货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | AZD2389是一种有效和口服活性的FAP抑制剂,能改善组织学纤维化改善和增加完整a2-AP,可用于研究代谢功能障碍相关的脂肪性肝炎。 |
| 别名 | AZD-2389, AZD 2389 |
| 分子量 | 411.48 |
| 分子式 | C20H21N5O3S |
| CAS No. | 2791472-12-1 |
| Smiles | C(NCC(=O)N1[C@H](C#N)CSC1)(=O)C=2C3=C(C=CC(=C3)N4CCOCC4)N=CC2 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (194.42 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 5 mg/mL (12.15 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | ||||||||||||||||||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多